Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 7 art units • 9 examiners • 0 of 11 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
UPL Corporation Limited has 11 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 9 distinct examiners and 7 distinct art units. The figures indicate a portfolio with several parallel examination relationships and some clustering within the technical organization.
SCHLIENTZ, NATHAN W is the busiest examiner with 2 pending matters. That examiner handles more than one matter, but the remaining workload is distributed among other examiners and art units. Counsel can use the shared technology area to coordinate substantive positions while maintaining separate response plans for each examination channel.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (45%) |
| Double-patenting + other | 3 (27%) |
| Multi-statute (no §101) | 3 (27%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLIENTZ, NATHAN W | 2 | 41.3% | -18.8% |
| KETCHAM, KAREN A | 2 | 19.6% | +37.2% |
| ANTHONY, JOSEPH DAVID | 1 | 73.2% | +5.3% |
| SHOMER, ISAAC | 1 | 63.1% | +30.5% |
| BROWE, DAVID | 1 | 26.7% | +28.0% |
| PHAN, DOAN THI-THUC | 1 | 42.8% | +47.6% |
| LOVE, TREVOR M | 1 | 43.1% | +26.8% |
| BOATENG, AFUA BAMFOAA | 1 | 46.7% | +64.5% |
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16423491 | BEAD COMPOSITIONS FOR AQUATIC WEED CONTROL | SAEED, ALI S | 147d overdue |
| 17615637 | Compositions of Dicarboxylic Acid Derivatives | SHOMER, ISAAC | 49d overdue |
| 17258525 | A STABLE LIQUID AGROCHEMICAL FORMULATION | KETCHAM, KAREN A | 5d |
| 19011836 | STABLE AGROCHEMICAL COMPOSITION | KETCHAM, KAREN A | — |
| 17603995 | A Stable Insecticide Composition | BROWE, DAVID | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16423491 | BEAD COMPOSITIONS FOR AQUATIC WEED CONTROL | SAEED, ALI S | 147d overdue |
| 17615637 | Compositions of Dicarboxylic Acid Derivatives | SHOMER, ISAAC | 49d overdue |
| 17040871 | FUNGICIDAL COMBINATIONS | LOVE, TREVOR M | 1d overdue |
| 17258525 | A STABLE LIQUID AGROCHEMICAL FORMULATION | KETCHAM, KAREN A | 5d |
| 17251579 | STABLE CO-FORMULATION OF BENZOYLUREA WITH PYRETHROIDS | PHAN, DOAN THI-THUC | 27d |
| 19011836 | STABLE AGROCHEMICAL COMPOSITION | KETCHAM, KAREN A | — |
| 17603995 | A Stable Insecticide Composition | BROWE, DAVID | — |
| 16980578 | HERBICIDAL COMBINATIONS | BOATENG, AFUA BAMFOAA | — |
| Art Unit | Apps |
|---|---|
| 1616 | 3 |
| 1614 | 2 |
| 1617 | 2 |
| 1764 | 1 |
| 1612 | 1 |
| 1613 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19198606 | FUNGICIDAL COMBINATIONS | SCHLIENTZ, NATHAN W | 1616 | §103§112DP | Non-Final OA | — | Pending | May 05, 2025 |
| 19011836 | STABLE AGROCHEMICAL COMPOSITION | KETCHAM, KAREN A | 1614 | §102§103 | Non-Final OA | — | Pending | Jan 07, 2025 |
| 17907810 | AN AGROCHEMICAL COMPOSITION | SCHLIENTZ, NATHAN W | 1616 | §102§103DP | Non-Final OA | — | Pending | Aug 29, 2022 |
| 17895733 | PROCESS FOR PREPARATION OF SUPERABSORBENT POLYMER | ANTHONY, JOSEPH DAVID | 1764 | §103DP | Non-Final OA | 79d | Pending | Aug 25, 2022 |
| 17615637 | Compositions of Dicarboxylic Acid Derivatives | SHOMER, ISAAC | 1612 | §103§112 | Final Rejection | 49d overdue | Pending | Dec 01, 2021 |
| 17603995 | A Stable Insecticide Composition | BROWE, DAVID | 1617 | §103 | Final Rejection | — | Pending | Oct 15, 2021 |
| 17258525 | A STABLE LIQUID AGROCHEMICAL FORMULATION | KETCHAM, KAREN A | 1614 | §103 | Final Rejection | 5d | Pending | Jan 07, 2021 |
| 17251579 | STABLE CO-FORMULATION OF BENZOYLUREA WITH PYRETHROIDS | PHAN, DOAN THI-THUC | 1613 | §103 | Final Rejection | 27d | Pending | Dec 11, 2020 |
| 17040871 | FUNGICIDAL COMBINATIONS | LOVE, TREVOR M | 1611 | §103 | Final Rejection | 1d overdue | Pending | Sep 23, 2020 |
| 16980578 | HERBICIDAL COMBINATIONS | BOATENG, AFUA BAMFOAA | 1617 | §103 | Non-Final OA | — | Pending | Sep 14, 2020 |
| 16423491 | BEAD COMPOSITIONS FOR AQUATIC WEED CONTROL | SAEED, ALI S | 1616 | §103§112 | Non-Final OA | 147d overdue | Pending | May 28, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUPL Corporation Limited has 11 pending office actions as of October 2026, spread across 7 art units and 9 examiners.
Nathan W Schlientz has the most, with 2 of UPL Corporation Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
